newsfilter
← Latest News
GlobeNewswire·

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

SAN DIEGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (Organovo), a clinical stage biotechnology company that is focused on developing novel human therapies with demonstrated function in